Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Mutation Detection in Patients with Retinal Dystrophies Using Targeted Next Generation Sequencing.

Weisschuh, Nicole ; Mayer, Anja K ; Strom, Tim M ; Kohl, Susanne ; Glöckle, Nicola ; Schubach, Max ; Andréasson, Sten LU ; Bernd, Antje ; Birch, David G and Hamel, Christian P , et al. (2016) In PLoS ONE 11(1).
Abstract
Retinal dystrophies (RD) constitute a group of blinding diseases that are characterized by clinical variability and pronounced genetic heterogeneity. The different nonsyndromic and syndromic forms of RD can be attributed to mutations in more than 200 genes. Consequently, next generation sequencing (NGS) technologies are among the most promising approaches to identify mutations in RD. We screened a large cohort of patients comprising 89 independent cases and families with various subforms of RD applying different NGS platforms. While mutation screening in 50 cases was performed using a RD gene capture panel, 47 cases were analyzed using whole exome sequencing. One family was analyzed using whole genome sequencing. A detection rate of 61%... (More)
Retinal dystrophies (RD) constitute a group of blinding diseases that are characterized by clinical variability and pronounced genetic heterogeneity. The different nonsyndromic and syndromic forms of RD can be attributed to mutations in more than 200 genes. Consequently, next generation sequencing (NGS) technologies are among the most promising approaches to identify mutations in RD. We screened a large cohort of patients comprising 89 independent cases and families with various subforms of RD applying different NGS platforms. While mutation screening in 50 cases was performed using a RD gene capture panel, 47 cases were analyzed using whole exome sequencing. One family was analyzed using whole genome sequencing. A detection rate of 61% was achieved including mutations in 34 known and two novel RD genes. A total of 69 distinct mutations were identified, including 39 novel mutations. Notably, genetic findings in several families were not consistent with the initial clinical diagnosis. Clinical reassessment resulted in refinement of the clinical diagnosis in some of these families and confirmed the broad clinical spectrum associated with mutations in RD genes. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and , et al. (More)
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; and (Less)
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
PLoS ONE
volume
11
issue
1
article number
e0145951
publisher
Public Library of Science (PLoS)
external identifiers
  • pmid:26766544
  • wos:000368459300011
  • scopus:84955493801
  • pmid:26766544
ISSN
1932-6203
DOI
10.1371/journal.pone.0145951
language
English
LU publication?
yes
id
9fd62587-dee3-412f-936d-afcf8a13447a (old id 8589150)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/26766544?dopt=Abstract
date added to LUP
2016-04-01 13:38:45
date last changed
2022-03-21 19:41:29
@article{9fd62587-dee3-412f-936d-afcf8a13447a,
  abstract     = {{Retinal dystrophies (RD) constitute a group of blinding diseases that are characterized by clinical variability and pronounced genetic heterogeneity. The different nonsyndromic and syndromic forms of RD can be attributed to mutations in more than 200 genes. Consequently, next generation sequencing (NGS) technologies are among the most promising approaches to identify mutations in RD. We screened a large cohort of patients comprising 89 independent cases and families with various subforms of RD applying different NGS platforms. While mutation screening in 50 cases was performed using a RD gene capture panel, 47 cases were analyzed using whole exome sequencing. One family was analyzed using whole genome sequencing. A detection rate of 61% was achieved including mutations in 34 known and two novel RD genes. A total of 69 distinct mutations were identified, including 39 novel mutations. Notably, genetic findings in several families were not consistent with the initial clinical diagnosis. Clinical reassessment resulted in refinement of the clinical diagnosis in some of these families and confirmed the broad clinical spectrum associated with mutations in RD genes.}},
  author       = {{Weisschuh, Nicole and Mayer, Anja K and Strom, Tim M and Kohl, Susanne and Glöckle, Nicola and Schubach, Max and Andréasson, Sten and Bernd, Antje and Birch, David G and Hamel, Christian P and Heckenlively, John R and Jacobson, Samuel G and Kamme, Christina and Kellner, Ulrich and Kunstmann, Erdmute and Maffei, Pietro and Reiff, Charlotte M and Rohrschneider, Klaus and Rosenberg, Thomas and Rudolph, Günther and Vámos, Rita and Varsányi, Balázs and Weleber, Richard G and Wissinger, Bernd}},
  issn         = {{1932-6203}},
  language     = {{eng}},
  number       = {{1}},
  publisher    = {{Public Library of Science (PLoS)}},
  series       = {{PLoS ONE}},
  title        = {{Mutation Detection in Patients with Retinal Dystrophies Using Targeted Next Generation Sequencing.}},
  url          = {{http://dx.doi.org/10.1371/journal.pone.0145951}},
  doi          = {{10.1371/journal.pone.0145951}},
  volume       = {{11}},
  year         = {{2016}},
}